Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: A population-based, nested case-control study

Drugs and Aging

Volumn 29, Issue 3, 2012, Pages 205-211

  Hutson, Janine R ^a   Fischer, Hadas D ^b   Wang, Xuesong ^b   Gruneir, Andrea ^b,c,d   Daneman, Nick ^b   Gill, Sudeep S ^b,e   Rochon, Paula A ^a,b,c,d   Anderson, Geoffrey M ^b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

Adverse drug reactions; Antibacterials; Cholinesterase inhibitors; Clarithromycin; Donepezil; Drug interactions; Elderly; Macrolides

Indexed keywords

AZITHROMYCIN; CEFUROXIME; CLARITHROMYCIN; DONEPEZIL; ERYTHROMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLONE DERIVATIVE;

AGED; ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COMPLETE HEART BLOCK; CONTROLLED STUDY; DRUG EXPOSURE; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SYNCOPE;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLINESTERASE INHIBITORS; CLARITHROMYCIN; COHORT STUDIES; CYTOCHROME P-450 CYP3A; DRUG INTERACTIONS; DRUG PRESCRIPTIONS; ENZYME INHIBITORS; FEMALE; HUMANS; INDANS; MACROLIDES; MALE; ONTARIO; PIPERIDINES; SYNCOPE;

EID: 84863285925     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11599090-000000000-00000     Document Type: Article

References (18)

1. McLaren AT, Allen J, Murray A, et al. Cardiovascular effects of donepezil in patients with dementia. Dement Geriatr Cogn Disord 2003; 15 (4): 183-8
2. Raschetti R,MagginiM, Sorrentino GC, et al. A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer s disease. Eur J Clin Pharmacol 2005; 61 (5-6): 361-8
3. Park-Wyllie LY, Mamdani MM, Li P, et al. Cholinesterase inhibitors and hospitalization for bradycardia: A populationbased study. PLoSMed 2009; 6 (9): E1000157
4. Gill SS, Anderson GM, Fischer HD, et al. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: A population-based cohort study. Arch Intern Med 2009; 169 (9): 867-73
5. Poluzzi E, Raschi E, Moretti U, et al. Drug-induced torsades de pointes: Data mining of the public version of the FDA Adverse Event Reporting System (AERS). Pharmacoepidemiol Drug Saf 2009; 18 (6): 512-8
6. Takaya T, Okamoto M, Yodoi K, et al. Torsades de Pointes with QT prolongation related to donepezil use. J Cardiol 2009; 54 (3): 507-11
7. Hernandez RK, Farwell W, Cantor MD, et al. Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the Veterans Affairs New England healthcare system. J Am Geriatr Soc 2009; 57 (11): 1997-2003
8. Yano R, Tani D, Watanabe K, et al. Evaluation of potential interaction between vinorelbine and clarithromycin. Ann Pharmacother 2009; 43 (3): 453-8
9. Wright AJ, Gomes T, Mamdani MM, et al. The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers. CMAJ 2011; 183 (3): 303-7
10. Loeb M, Simor AE, Landry L, et al. Antibiotic use in Ontario facilities that provide chronic care. J Gen Intern Med 2001; 16 (6): 376-83
11. Hanlon JT, Sloane RJ, Pieper CF, et al. Association of adverse drug reactions with drug-drug and drug-disease interactions in frail older outpatients. Age Ageing 2011; 40 (2): 274-7
12. Fischer HD, Juurlink DN,MamdaniMM, et al. Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: A population-based study. Arch Intern Med 2010; 170 (7): 617-21
13. Park-Wyllie LY, Juurlink DN, Kopp A, et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006; 354 (13): 1352-61
14. Gomes T, Mamdani MM, Juurlink DN. Macrolide-induced digoxin toxicity: A population-based study. Clin Pharmacol Ther 2009; 86 (4): 383-6
15. Tiseo PJ, Perdomo CA, Friedhoff LT. Concurrent administration of donepezil HCl and cimetidine: Assessment of pharmacokinetic changes following single and multiple doses. Br J Clin Pharmacol 1998; 46 Suppl. 1: 25-9
16. Tiseo PJ, Perdomo CA, Friedhoff LT. Concurrent administration of donepezil HCl and ketoconazole: Assessment of pharmacokinetic changes following single and multiple doses. Br J Clin Pharmacol 1998; 46 Suppl. 1: 30-4
17. Varsaldi F, Miglio G, Scordo MG, et al. Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil inAlzheimer s disease patients. Eur J Clin Pharmacol 2006; 62 (9): 721-6
18. Mandell LA, Marrie TJ, Grossman RF, et al. Canadian guidelines for the initial management of communityacquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 2000; 31 (2): 383-421